StonvexLoading…
StonvexStonvexStonvexCore line items from ORA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $403.91M | $989.54M | $713.51M | $463.78M |
Operating Income | $80.25M | $169.22M | $126.66M | $86.23M |
Net Income | $44.07M | $123.90M | $92.55M | $68.41M |
EPS (Diluted) | $0.71 | $2.02 | $1.51 | $1.12 |
Total Assets | $6.77B | $6.25B | $6.09B | $6.02B |
Total Liabilities | $4.05B | $3.56B | $3.44B | $3.39B |
Cash & Equivalents | $654.64M | $147.45M | $79.56M | $88.49M |
Free Cash Flow OCF − CapEx | $-35.21M | $-284.68M | $-244.63M | $-142.52M |
Shares Outstanding | 61.45M | 60.85M | 60.78M | 60.72M |